{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:41:32Z","timestamp":1791175292418,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GVHD is still one of the major complications after allogeneic stem cell transplantation. Whereas murine data have clearly shown the beneficial effects of regulatory T cells (Tregs) on the prevention of GVHD, data from the human system are rare. Here, we present a comparative dynamic analysis of CD4+CD25hiCD127lo\/\u2212 Tregs from patients with and without GVHD analyzing the whole genome profile over the first 6 months after stem cell transplantation, representing the most sensitive time window for tolerance induction. The Treg transcriptome showed a high stability. However, the comparison of Treg transcriptomes from patients with and without GVHD uncovered regulated gene transcripts highly relevant for Treg cell function. The confirmative protein analyses demonstrated a significantly higher expression of granzyme A, CXCR3, and CCR5 in Tregs of immune tolerant patients. These results point to a reduced suppressive function of Tregs from GVHD patients with diminished migration capacity to the target organs.<\/jats:p>","DOI":"10.1182\/blood-2011-05-352708","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T03:18:21Z","timestamp":1311304701000},"page":"e82-e92","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":61,"title":["Human regulatory T cells in allogeneic stem cell transplantation"],"prefix":"10.1182","volume":"118","author":[{"given":"Sya N.","family":"Ukena","sequence":"first","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvari","family":"Velaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Geffers","sequence":"additional","affiliation":[{"name":"Service Unit, Gene Expression Analysis, Helmholtz Centre for Infection Research, Braunschweig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Grosse","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Baron","sequence":"additional","affiliation":[{"name":"Epiontis GmbH, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Buchholz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Bruder","sequence":"additional","affiliation":[{"name":"Department of Infection and Immunity, Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Franzke","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2019111807284864700_B1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation.","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807284864700_B2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self.","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111807284864700_B3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2004-01-0328","article-title":"Recipient CD4(+) T cells that survive irradiation regulate chronic graft-versus-host disease.","volume":"104","author":"Anderson","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111807284864700_B4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease.","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"2019111807284864700_B5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"2019111807284864700_B6","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2019111807284864700_B7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3(+) regulatory T cells in the human immune system.","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111807284864700_B8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4049\/jimmunol.179.2.744","article-title":"Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4(+)CD25(+) regulatory T cells.","volume":"179","author":"Bollyky","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"2019111807284864700_B9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2005-06-2277","article-title":"Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44.","volume":"107","author":"Firan","year":"2006","journal-title":"Blood"},{"key":"2019111807284864700_B10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6150-4-40","article-title":"CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4(+) T-reg cells.","volume":"4","author":"Liu","year":"2009","journal-title":"Biol Direct"},{"issue":"5","key":"2019111807284864700_B11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of Foxp3(+) T regulatory cell-mediated suppression.","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"2019111807284864700_B12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4906(02)02232-9","article-title":"Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?","volume":"23","author":"Rabinovich","year":"2002","journal-title":"Trends Immunol"},{"issue":"9","key":"2019111807284864700_B13","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","article-title":"Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells.","volume":"104","author":"Grossman","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111807284864700_B14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20031562","article-title":"Developmental stage, phenotype, and migration distinguish naive- and effector\/memory-like CD4(+) regulatory T cells.","volume":"199","author":"Huehn","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"2019111807284864700_B15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunological self-tolerance maintained by activated T-cells expressing Il-2 receptor alpha-chains (Cd25): breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases.","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"2","key":"2019111807284864700_B16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood-2002-09-2748","article-title":"Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.","volume":"102","author":"Ichiba","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111807284864700_B17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbmt.2005.01.004","article-title":"Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.","volume":"11","author":"Jaksch","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111807284864700_B18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2004-08-2996","article-title":"CCR6 regulates CD4(+) T-cell-mediated acute graft-versus-host disease responses.","volume":"106","author":"Varona","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111807284864700_B19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.exphem.2003.12.003","article-title":"An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.","volume":"32","author":"Welniak","year":"2004","journal-title":"Exp Hematol"},{"issue":"10","key":"2019111807284864700_B20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-472X(03)00198-X","article-title":"Role of CXCR3-induced donor T-cell migration in acute GVHD.","volume":"31","author":"Duffner","year":"2003","journal-title":"Exp Hematol"},{"issue":"2","key":"2019111807284864700_B21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4049\/jimmunol.173.2.845","article-title":"Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.","volume":"173","author":"Wysocki","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"2019111807284864700_B22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"14","key":"2019111807284864700_B23","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.","volume":"117","author":"di Ianni","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111807284864700_B24","first-page":"825","article-title":"Consensus Conference on Acute Gvhd Grading.","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807284864700_B25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2350-6-43","article-title":"The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.","volume":"13","author":"Ukena","year":"2005","journal-title":"BMC Med Genet"},{"issue":"12","key":"2019111807284864700_B26","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1371\/journal.pone.0001308","article-title":"Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.","volume":"12;2","author":"Ukena","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"2019111807284864700_B27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbt.2008.08.005","article-title":"Microfluidic-based enzymatic on-chip labeling of miRNAs.","volume":"25","author":"Vorwerk","year":"2008","journal-title":"N Biotechnol"},{"issue":"2","key":"2019111807284864700_B28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/0008-5472.CAN-08-2361","article-title":"Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.","volume":"69","author":"Wieczorek","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"2019111807284864700_B29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2007-03-079160","article-title":"Reconstitution of FOXP3(+) regulatory T cells (T-regs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease.","volume":"110","author":"Mielke","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111807284864700_B30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (T-reg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2019111807284864700_B31","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3(+) CD4(+)CD25(+) regulatory T cells in patients with chronic graft-versus-host disease.","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2019111807284864700_B32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","article-title":"Mucosal Foxp3(+) regulatory T cells are numerically deficient in acute and chronic GVHD.","volume":"107","author":"Rieger","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111807284864700_B33","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L(+) subpopulation of CD4(+)CD25(+) regulatory T cells protects from lethal acute GVHD.","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019111807284864700_B34","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","article-title":"L-Selectin(hi) but not the L-selectin(lo) CD4(+)25(+) T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.","volume":"104","author":"Taylor","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2019111807284864700_B35","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2005-04-1632","article-title":"Critical role for CCR5 in the function of donor CD4(+)CD25(+) regulatory T cells during acute graft-versus-host disease.","volume":"106","author":"Wysocki","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019111807284864700_B36","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.exphem.2008.07.007","article-title":"Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.","volume":"36","author":"Takahashi","year":"2008","journal-title":"Exp Hematol"},{"issue":"3","key":"2019111807284864700_B37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.gt.3303051","article-title":"Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.","volume":"15","author":"Hasegawa","year":"2008","journal-title":"Gene Ther"},{"issue":"2","key":"2019111807284864700_B38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri2474","article-title":"Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?","volume":"9","author":"Huehn","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2019111807284864700_B39","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/bmt.2008.37","article-title":"Cell cycle and immune-related processes are significantly altered in chronic GVHD.","volume":"41","author":"Oh","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111807284864700_B40","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2009-07-233676","article-title":"Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.","volume":"115","author":"Cai","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111807284864700_B41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4049\/jimmunol.170.2.805","article-title":"The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.","volume":"170","author":"Hirst","year":"2003","journal-title":"J Immunol"},{"issue":"6558","key":"2019111807284864700_B42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/378736a0","article-title":"Apoptosis of T-cells mediated by galectin-1.","volume":"378","author":"Perillo","year":"1995","journal-title":"Nature"},{"issue":"3","key":"2019111807284864700_B43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2003.08.003","article-title":"Amelioration of graft versus host disease by galectin-1.","volume":"109","author":"Baum","year":"2003","journal-title":"Clin Immunol"},{"issue":"24","key":"2019111807284864700_B44","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","article-title":"Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.","volume":"23","author":"Schmid","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/13\/e82\/1344974\/zh803911000e82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/13\/e82\/1344974\/zh803911000e82.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T23:05:08Z","timestamp":1712617508000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/13\/e82\/29323\/Human-regulatory-T-cells-in-allogeneic-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,29]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,9,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-05-352708","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,29]]}}}